Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-05526 |
Siglec-15 Protein, Human, Recombinant (His)
SIGLEC-15,sialic acid binding Ig-like lect... |
Human | HEK293 Cells |
Siglec-15 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 27.7 kDa and the accession number is Q6ZMC9-1. | |||
TMPY-05736 |
Siglec-15 Protein, Human, Recombinant (mFc)
HsT1361,SIGLEC-15,CD33L3,sialic acid bindi... |
Human | HEK293 Cells |
Siglec-15 Protein, Human, Recombinant (mFc) is expressed in HEK293 mammalian cells with mFc tag. The predicted molecular weight is 52.79 kDa and the accession number is Q6ZMC9-1. | |||
TMPJ-00225 |
Siglec-15 Protein, Mouse, Recombinant (His)
Siglec-15,Sialic acid-binding Ig-like lect... |
Mouse | HEK293 Cells |
Human Siglec-15 is a transmembrane glycoprotein in the Siglec family. Siglecs are type I transmembrane proteins where the NH3+-terminus is in the extracellular space and the COO−-terminus is cytosolic. Each Siglec contains an N-terminal V-type immunoglobulin domain (Ig domain) which acts as the binding receptor for sialic acid. These lectins are placed into the group of I-type lectins because the lectin domain is an immunoglobulin fold. All Siglecs are extended from the cell surface by C2-type I... | |||
TMPY-05835 |
Siglec-15 Protein, Mouse, Recombinant (rFc)
Cd33l3,SIGLEC-I,EG620235,sialic acid binding Ig-lik... |
Mouse | HEK293 Cells |
Siglec-15 Protein, Mouse, Recombinant (rFc) is expressed in HEK293 mammalian cells with rFc tag. The predicted molecular weight is 50.83 kDa and the accession number is A7E1W8. | |||
TMPK-01295 |
Siglec-15 Protein, Cynomolgus, Recombinant (His & Avi)
CD33 molecule-like 3,Siglec15,CD33 antigen... |
Cynomolgus | HEK293 Cells |
Siglec-15 is a transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-15 consists of a 244 amino acid extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates. Siglec-15 Protein, Cynomolgus, Recombinant (His & Avi) is expressed in HEK293 mam... | |||
TMPJ-00434 |
Siglec-15 Protein, Cynomolgus, Recombinant (His)
Siglec-15,CD33L3,Sialic acid-binding Ig-li... |
Cynomolgus | HEK293 Cells |
Siglec-15 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 30-40 KDa and the accession number is A0A2K5UY47. | |||
TMPJ-00217 |
Siglec-15 Protein, Human, Recombinant (hFc & Avi), Biotinylated
CD33L3,Siglec-15,Sialic acid-binding Ig-li... |
Human | HEK293 Cells |
Siglec-15 Protein, Human, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-Fc-Avi tag. The predicted molecular weight is 58-75 KDa and the accession number is Q6ZMC9. | |||
TMPK-00217 |
Siglec-15 Protein, Human, Recombinant (His & Avi)
Siglec15,CD33 molecule-like 3,HsT1361,CD33... |
Human | HEK293 Cells |
Siglec-15 is a transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-15 consists of a 244 amino acid extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates.. | |||
TMPK-01296 |
Siglec-15 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated
CD33 molecule-like 3,CD33L3,Siglec15,S... |
Cynomolgus | HEK293 Cells |
Siglec-15 is a transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-15 consists of a 244 amino acid extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates. Siglec-15 Protein, Cynomolgus, Recombinant (His & Avi), Biotinylated is expressed... | |||
TMPK-00231 |
Siglec-15 Protein (Primary Amine Labeling), Mouse, Recombinant (His), Biotinylated
CD33 molecule-like 3,Siglec15,CD33L3,HsT13... |
Mouse | HEK293 Cells |
Siglec-15 is a transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-15 consists of a 244 amino acid extracellular domain (ECD) with two Ig-like domains, a 21 aa transmembrane segment, and a 44 aa cytoplasmic domain. Siglec-15 is a potential therapeutic target for osteoporosis and plays a conserved regulatory role in the immune system of vertebrates. Siglec-15 Protein (Primary Amine Labeling), Mouse, Recombinant (His), Biotinylate... | |||
TMPY-05678 |
Siglec-15 Protein, Cynomolgus, Recombinant (hFc)
sialic acid binding Ig-like lectin 15 |
Cynomolgus | HEK293 Cells |
Siglec-15 Protein, Cynomolgus, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 53 kDa and the accession number is A0A2K5UY47. | |||
TMPY-00803 |
Fibronectin Protein, Human, Recombinant (aa 607-1265, His)
GFND,LETS,ED-B,fibronectin 1,CIG,GFND2,FNZ,FINC,FN,MSF |
Human | HEK293 Cells |
Fibronectin Protein, Human, Recombinant (aa 607-1265, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 73.2 kDa and the accession number is P02751-15. | |||
TMPY-05562 |
Fibronectin Protein, Human, Recombinant (aa 1722-1811, His)
fibronectin 1,ED-B,CIG,FNZ,MSF,FN,FINC,GFND,LETS,GFND2 |
Human | HEK293 Cells |
Fibronectin Protein, Human, Recombinant (aa 1722-1811, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 11.3 kDa and the accession number is P02751-15. | |||
TMPK-01416 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,SARS-CoV-2 epitope |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPK-01412 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi)
SARS-CoV-2 epitope,MHC |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. |